Short Summary
The PTAB granted institution of an IPR on Intercurrency Software’s 10,776,863 patent covering a consolidated trading platform, finding a reasonable likelihood of unpatentability for claims 1‑12 based on obviousness over multiple prior‑art references.
Detailed Summary
In IPR2024‑00375, the Patent Trial and Appeal Board evaluated a petition by Askeladden L.L.C. (Wise PLC) challenging claims 1‑12 of Intercurrency Software’s U.S. Patent No. 10,776,863 B1, which claims a three‑tier architecture for cross‑border trading with real‑time currency conversion. The petitioner relied on a combination of prior‑art references—Calo, Rude, Sellberg, Szoc, Davidowitz, and Kedia—to argue obviousness under 35 U.S.C. § 103. After applying the § 314(a) standard, the Board concluded there was a reasonable likelihood that the petitioner would prevail on at least one claim and therefore instituted the inter partes review on all challenged claims and grounds. No final validity determination was made; the proceeding will now proceed to trial.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Wise PLC et al. vs -- is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Google LLCvsSecure Communication Technologies, LLC
Google has filed an IPR petition challenging Secure Communication Technologies' U.S. Patent 8,116,749, arguing that the claims are obvious over existing e‑commerce server technologies. The petition seeks institution of the review under §103.
Mianyang BOE Optoelectronics Technology Co., Ltd. et al.vsSamsung Display Co., Ltd.
BOE and affiliates filed a joint notice that a redacted version of the PTAB’s final written decision in Samsung Display’s OLED display patent case has been prepared. The redactions protect confidential material while allowing the decision to be filed.
Liberty Energy, Inc. et al.vsU.S. Well Services, LLC
Court decision.
Imperative Care, Inc.vsInari Medical, Inc.
Imperative Care seeks an IPR on Inari Medical’s 11,697,012 catheter‑hemostasis valve patent, asserting anticipation and obviousness over Schaffer and related references. The petition argues the preamble term “aspiration” is non‑limiting and requests the Board to institute the review.
Senko Advanced Components, Inc.vsUS Conec Ltd.
Senko Advanced Components and US Conec jointly filed a motion to keep their settlement agreement confidential and to withdraw the PGR petition, effectively ending the PTAB review of patent 11,808,994.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.